Enjoy complimentary customisation on priority with our Enterprise License!
Several diagnostic tests are conducted to detect genetically inherited cystic fibrosis (CF) disease. Some of the recommended diagnosis tests are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests. The increasing awareness and high investment will enhance the diagnostic technologies and ease the detection of such genetic diseases. Technavio’s market research report has identified improved diagnostic technologies as one of the primary factors that will trigger the growth of the cystic fibrosis therapeutics market in the next five years.
In the recent times, several advanced diagnostic methods are adopted for detecting cystic fibrosis. For example, DNA test for comprehensive and accurate screening of newborns for CF involves next generation DNA sequencing which helps in detecting the entire CFTR gene. Moreover, this method is less time-consuming. Our market research analysts estimate the cystic fibrosis therapeutics market to grow steadily at a CAGR more than 17% by 2022.
The growing strategic collaboration is one of the key trends contributing towards the growth of the cystic fibrosis (CF) therapeutics market. Companies are extensively entering into M&A to increase the market penetration and improve the company’s product portfolio. This process significantly contributes to symbiotic relation among the companies as the companies exchange their technical expertise and ensures sufficient funds for R&D. To increase the global footprint, the vendors are focusing on making acquisition strategies and expand the product line.
The cystic fibrosis diagnosis market is fragmented due to the presence of several players. This industry research report provides a detailed information of the competitive environment among the players in this market space. Moreover, our analysts also provide strategies and areas that the vendors should follow to improve their market shares and sustain the competitive environment in the cystic fibrosis therapeutics market.
According to our market research experts, the following are some of the companies in the cystic fibrosis therapeutics market.
This market study estimates that in terms of geographic regions, the Americas will be the major revenue contributor to the cystic fibrosis (CF) therapeutics market throughout the forecast period. This region is expected to witness significant growth during the forecast period due to the high investments in the healthcare sector by the economic giants.
Want a bigger picture? Try a FREE sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MARKET LANDSCAPE
PART 06: MARKET SIZING
PART 07: FIVE FORCES ANALYSIS
PART 08: MARKET SEGMENTATION BY DRUG CLASS
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.